Position in REGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$74,201
-$62,430 QoQ
Shares Held
119
-51.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,102
of 1,322 holders
Holding Since
Mar 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026State of Wyoming holds $40,938,454 across 171 Biotechnology names. REGN ranks #100 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
35,525 | $4,027,114 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
8,698 | $2,478,669 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
4,767 | $1,771,750 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
9,446 | $1,769,046 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
11,780 | $1,350,812 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,410 | $1,294,049 | |
| 7 | ACAD |
Acadia Pharmaceuticals Inc
|
48,794 | $1,234,488 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
2,768 | $926,698 |
All Filings in REGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $74,201 | 119 | Shares | Sole | 2026-08-06 | |
| 2025-09-30 | $136,631 | 243 | Shares | Sole | 2025-11-04 | |
| 2022-06-30 | $83,940 | 142 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $246,542 | 353 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $179,983 | 285 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $151,295 | 250 | Shares | Sole | 2022-02-14 | |
| 2021-06-30 | $84,339 | 151 | Shares | Sole | 2022-02-14 | |
| 2021-03-31 | $125,382 | 265 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||